Status
Conditions
Treatments
About
Platinum-sensitive is an important basis for the treatment of recurrent epithelial ovarian cancer (EOC) without effective methods to predict.We aimed to develop and validate the EOC deep learning system to predict the platinum-sensitive of EOC patients through analysis of enhanced magnetic resonance imaging (MRI) images before initial treatment.Ninety-three EOC patients received platinum-based chemotherapy (>= 4 cycles) and debulking surgery from Sun Yat-sen Memorial Hospitalin China from January 2011 to January 2020 were enrolled. This deep-learning EOC signature achieved a high predictive power for platinum-sensitive, and the signature based on MRI whole volume is better than that on primary tumor area only.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
93 participants in 2 patient groups
Loading...
Central trial contact
Ruilin Lei, phD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal